Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleFeature: Research Highlights, Disorders of the Nervous System

Potential Protein Target to Therapeutically Restore Positive Mood States in Depression

Rosalind S.E. Carney DPhil
eNeuro 28 March 2019, 6 (2) ENEURO.0105-19.2019; DOI: https://doi.org/10.1523/ENEURO.0105-19.2019
Rosalind S.E. Carney DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Highlighted Research Paper: Disorders of the Nervous System Highlighted Research Paper: p11 in Cholinergic Interneurons of the Nucleus Accumbens Is Essential for Dopamine Responses to Rewarding Stimuli, by Y. Hanada, Y. Kawahara, Y. N. Ohnishi, T. Shuto, M. Kuroiwa, N. Sotogaku, P. Greengard, Y. Sagi, and A. Nishi.

Major depression is one of the most common mental health disorders; meta-analysis of 83 cross-sectional studies found a 27% pooled prevalence of depression or depression-like symptoms among outpatients (Wang et al., 2017). Symptoms of depression include mood states of increased negative affect such as depressed mood, suicidality, fatigue, guilt, reduced focus, and feelings of worthlessness (American Psychiatric Association, 2013). Antidepressant treatments that target serotonergic signaling help alleviate some of these symptoms. However, current treatments do not adequately mitigate symptoms of decreased positive affect in which individuals experience less interest in social and physical interactions. This loss of interest in normally pleasurable events, termed anhedonia, is associated with a reduction in dopaminergic neurotransmission (Der-Avakian and Markou, 2012; Russo and Nestler, 2013). In their eNeuro publication, Hanada et al. (2018) found that the p11 (S100A10) protein, a member of the S100 EF-hand family, functions in reward-mediated dopamine release, and therefore therapeutic strategies that increase the function of p11 may have an impact on antidepressant efficacy in alleviating anhedonia.

The mesolimbic reward circuit is mediated by dopaminergic input from the ventral tegmental area to the nucleus accumbens (NAc). Within the NAc, dopamine release is stimulated by the release of acetylcholine (ACh) from cholinergic interneurons (CINs), which express high levels of p11. Postmortem tissue from humans with depression reveals reduced p11 expression in the NAc (Svenningsson et al., 2006; Alexander et al., 2010). Restoration of p11 expression locally in the NAc of p11 knock-out (KO) mice reverses depression-like behaviors (Alexander et al., 2010). When p11 is specifically deleted in choline acetyltransferase (ChAT)-expressing cells (ChAT-p11 cKO) in the NAc, mice exhibit depression-like behaviors (Warner-Schmidt et al., 2012). These prior studies confirmed that p11 in CINs of the NAc regulates depression-like behaviors, but a direct link between p11 and dopaminergic transmission had not yet been established. To investigate whether p11 could directly impact dopaminergic neurotransmission, Hanada et al. (2018) placed microdialysis probes in the NAc of wild-type (WT), p11 KO, and ChAT-p11 cKO mice. Microdialysis enabled real-time measurements of changes in extracellular neurotransmitter levels in vivo upon exposure to one of three reward stimuli.

In WT mice, exposure to cocaine, palatable food, or a female mouse increased extracellular dopamine (DA) levels in the NAc. In p11 KO mice, the DA response was largely attenuated in response to cocaine infusion and was abolished following exposure to palatable food or a female mouse. These results indicate that p11 selectively regulates DA-mediated reward responses in the NAc. The authors then assessed the effects of ACh receptor activation in p11 KO mice using nicotinic ACh receptor (nAChR) and muscarinic ACh receptor (mAChR) agonists. When the nAChR agonist, nicotine, or a non-selective mAChR agonist, oxotremorine, was co-infused into the NAc with cocaine, extracellular DA levels in p11 KO mice were increased similarly to those in WT mice. These experiments indicate that when ACh receptors presumably located at dopaminergic terminals are stimulated, the DA response to cocaine is restored in p11 KO mice. Therefore, endogenous p11 functions to stimulate ACh release and regulates the ACh-mediated DA response to rewarding stimuli.

To confirm that p11 in NAc CINs mediates the DA response to rewarding stimuli, Hanada et al. (2018) repeated the microdialysis experiments in ChAT-p11 cKO mice. Loss of p11 function in ChAT-expressing cells resulted in attenuated DA responses to cocaine infusion, palatable food, or female exposure in the NAc (Fig. 1). These attenuated DA responses were restored by overexpression of p11 in NAc CINs of ChAT-p11 cKO mice. Chemogenetic alteration of CIN activity in ChAT-p11 cKO mice also supports the concept that p11 function in CINs is a critical regulator of the DA response to rewarding stimuli in the NAc. Microdialysis measurement of extracellular ACh levels after cocaine infusion into the NAc of ChAT-p11 cKO mice confirmed the concept that p11 functions endogenously in CINs to regulate ACh release, which in turn enhances DA release in the NAc.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

DA response to rewarding stimuli in the NAc of ChAT-p11 cKO mice. Extracellular levels of DA in the NAc of WT and ChAT-p11 cKO mice following cocaine infusion into the NAc (A), exposure to palatable food (B), and exposure to female mice (C). The basal values for each group were obtained as the average of three stable baseline samples, and all values are calculated as a percentage of the basal values within the same group (100%). Data represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 versus WT mice; two-way ANOVA and Bonferroni multiple comparison: †p < 0.05, ††p < 0.01, †††p < 0.001 versus the basal levels of DA in the same group. The number of mice is indicated in parentheses (adapted from Hanada et al., 2018, their Fig. 3).

This eNeuro publication is an important advance in the field because the findings implicate loss of p11 function as a critical factor that results in the attenuated ACh release and impaired dopaminergic transmission that underlies anhedonia (Fig. 2). As there is an association between anhedonia and suicidality, substance abuse, and schizophrenia (Craske et al., 2016; Loas et al., 2018), it is imperative to develop therapeutic treatments that maintain positive affect in depression. Positive and negative affects are not extreme mood states on the same mood spectrum; rather they represent two independent dimensions (Watson and Clark, 1997). Therefore, it will hopefully be possible to maintain or increase positive affect and simultaneously decrease negative affect in depressed individuals. However, as p11 potentiates serotonergic transmission (Svenningsson et al., 2006; Warner-Schmidt et al., 2009), it is not known how difficult it would be to achieve dual-affect treatment(s). But for now, this eNeuro publication opens up the potential for the development of antidepressant treatments that can reduce symptoms of anhedonia in individuals with depression.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Schematic illustration of the role of p11 in the dopamine response to rewarding stimuli (visual abstract from Hanada et al., 2018).

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, Vernov M, Stavarache M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG (2010) Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med 2:54ra76. doi:10.1126/scitranslmed.3001079 pmid:20962330
    OpenUrlAbstract/FREE Full Text
  2. ↵
    American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, Ed 5. Arlington, VA: American Psychiatric. [CrossRef]
  3. ↵
    Craske MG, Meuret AE, Ritz T, Treanor M, Dour HJ (2016) Treatment for anhedonia: a neuroscience driven approach. Depress Anxiety 33:927–938. doi:10.1002/da.22490 pmid:27699943
    OpenUrlCrossRefPubMed
  4. ↵
    Der-Avakian A, Markou A (2012) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35:68–77. doi:10.1016/j.tins.2011.11.005 pmid:22177980
    OpenUrlCrossRefPubMed
  5. ↵
    Hanada Y, Kawahara Y, Ohnishi YN, Shuto T, Kuroiwa M, Sotogaku N, Greengard P, Sagi Y, Nishi A (2018) p11 in Cholinergic Interneurons of the Nucleus Accumbens Is Essential for Dopamine Responses to Rewarding Stimuli. eNeuro 5:ENEURO.0332-18.2018. doi:10.1523/ENEURO.0332-18.2018
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Loas G, Lefebvre G, Rotsaert M, Englert Y (2018) Relationships between anhedonia, suicidal ideation and suicide attempts in a large sample of physicians. PLoS One 13:e0193619. doi:10.1371/journal.pone.0193619
    OpenUrlCrossRefPubMed
  7. ↵
    Russo SJ, Nestler EJ (2013) The brain reward circuitry in mood disorders. Nat Rev Neurosci 14:609–625. doi:10.1038/nrn3381 pmid:23942470
    OpenUrlCrossRefPubMed
  8. ↵
    Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, Greengard P (2006) Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311:77–80. doi:10.1126/science.1117571 pmid:16400147
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Wang J, Wu X, Lai W, Long E, Zhang X, Li W, Zhu Y, Chen C, Zhong X, Liu Z, Wang D, Lin H (2017) Prevalence of depression anddepressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open 7:e017173. doi:10.1136/bmjopen-2017-017173
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Warner-Schmidt JL, Flajolet M, Maller A, Chen EY, Qi H, Svenningsson P, Greengard P (2009) Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci 29:1937–1946. doi:10.1523/JNEUROSCI.5343-08.2009 pmid:19211900
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Warner-Schmidt JL, Schmidt EF, Marshall JJ, Rubin AJ, Arango-Lievano M, Kaplitt MG, Ibañez-Tallon I, Heintz N, Greengard P (2012) Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc Natl Acad Sci U S A 109:11360–11365. doi:10.1073/pnas.1209293109 pmid:22733786
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Watson D, Clark LA (1997) Measurement and mismeasurement of mood: Recurrent and emergent issues. J Person Assess 68:267–296. doi:10.1207/s15327752jpa6802_4 pmid:16370781
    OpenUrlCrossRefPubMed
Back to top

In this issue

eneuro: 6 (2)
eNeuro
Vol. 6, Issue 2
March/April 2019
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Potential Protein Target to Therapeutically Restore Positive Mood States in Depression
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Potential Protein Target to Therapeutically Restore Positive Mood States in Depression
Rosalind S.E. Carney
eNeuro 28 March 2019, 6 (2) ENEURO.0105-19.2019; DOI: 10.1523/ENEURO.0105-19.2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Potential Protein Target to Therapeutically Restore Positive Mood States in Depression
Rosalind S.E. Carney
eNeuro 28 March 2019, 6 (2) ENEURO.0105-19.2019; DOI: 10.1523/ENEURO.0105-19.2019
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Feature: Research Highlights

  • Under Pressure: A Microfluidic Chip for Prolonged, Anesthetic-Free Imaging of Neuronal Mitostasis in Caenorhabditis elegans
  • AMPA Receptors Exist in Tunable Mobile and Immobile Synaptic Fractions In Vivo
  • Behavioral Responses to Neural Circuit Control: Pitfalls and Possible Solutions
Show more Feature: Research Highlights

Disorders of the Nervous System

  • Identification of a Novel Axon Regeneration Role for Non-Canonical Wnt Signaling in the Adult Retina After Injury
  • Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism
  • Extrahippocampal Seizure and Memory Circuits Overlap
Show more Disorders of the Nervous System

Subjects

  • Research Highlights

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2022 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.